InsidersTradesSigma
Discover the complete record of transactions filed by Verma Ajay, Director. Director active across 1 companies, notably Yumanity Therapeutics, INC.. Aggregated, 2 filings have been logged. The latest transaction was filed on 1 December 2021 (Attribution). Regulator: SEC (Form 4). All data is openly available.
2 of 2 declarations
Verma Ajay is Executive Vice President and Head of R&D at Yumanity Therapeutics, Inc. He leads research efforts to develop innovative treatments in the field of neurodegenerative diseases.